Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians

Osteoporosis Clinical Trial

Official title:

Study AGE - Part 2 (Active Geriatric Evaluation for General Practitioner), Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01816087
• Other study ID #: 287/2012
• Status: Completed
• Phase: N/A
• First received: February 20, 2013
• Last updated: January 5, 2018
• Start date: May 2013
• Est. completion date: November 2014

Study information

• Verified date: January 2018
• Source: University of Lausanne
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The AGE (Active Geriatric Evaluation) aims to develop a brief assessment tool adapted to the primary care setting.

Description:

The AGE (Active Geriatric Evaluation) program is a collaborative project between a primary care institution and a specialised geriatric unit that aims to develop a brief assessment tool (BAT) adapted to the primary care setting. The objective of this study is to assess the performances of the BAT to identify major geriatric syndromes: cognitive impairment; mood disorder; functional impairment; urinary incontinence; malnutrition; gait and balance impairment; osteoporosis; hearing impairment; visual impairment.

In order to achieve our objective, we plan to recruit 155 patients > 70 years old in primary care settings for which primary care physicians will perform the BAT (composed of specific questions and clinical exams). At the end of the consultation, the primary care physician will fill a questionnaire where the absence/presence of syndromes will be recorded (according to the findings of the BAT). Each patient will be then seen a second time by expert geriatricians that will perform a full geriatric evaluation (90 minutes). This will allow to calculate the performances of the intervention (BAT) in terms of sensibility /specificity,...

Recruitment information / eligibility

• Status: Completed
• Enrollment: 86
• Est. completion date: November 2014
• Est. primary completion date: November 2014
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 70 Years and older

Eligibility

Inclusion Criteria:

• Age > 70 years

• follow-up by general practitioner

• good understanding of french or presence of a translater

• No previous or on-going geriatric consultation

• Patient able to provide consent or a relative is present that can provide a consent instead

Exclusion Criteria:

• Age < 70 years

• No follow-up by general practitioner

• Unable to understand French or absence of a translater

• On-going geriatric follow-up

• Patient unable to provide consent or a relative is absent

Related Conditions & MeSH terms

• Cognitive Dysfunction
• Cognitive Impairment
• Deafness
• Enuresis
• Hearing Impairment
• Hearing Loss
• Malnutrition
• Mood Disorders
• Osteoporosis
• Urinary Incontinence
• Vision Disorders
• Visual Impairment

Intervention

Other:
• brief geriatric assessment
All participants will be screened for geriatric syndromes using the brief assessment tool. Mix a simple questions and simple tests

Locations

Country	Name	City	State
Switzerland	Departement of Ambulatory Care and Community Medicine	Lausanne	VD

Sponsors (1)

Lead Sponsor	Collaborator
University of Lausanne

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Sensibility and specificity	performances of the brief assessment tool (BAT) will be measured by calculating sensibility and specificity for each of the geriatric syndromes: cognitive impairment; mood disorder; functional impairment; urinary incontinence; malnutrition; gait and balance impairment; osteoporosis; hearing impairment; visual impairment	one year